← Back to Search

Telemedicine for Psoriatic Arthritis (PsOWell Trial)

N/A

Recruiting

Led By Alexis Ogdie-Beatty, MD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Active symptoms of PsA as defined by a PsA Impact of Disease (PsAID) questionnaire score >4 or a patient global assessment of greater than 4

Age 18-89

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 months

Awards & highlights

PsOWell Trial Summary

This trial will test if telemedicine visits can help people with PsA improve their quality of life and reduce disease activity.

Who is the study for?

This trial is for adults aged 18-89 with active psoriatic arthritis symptoms, stable on current therapy, and not planning to change treatment soon. Participants must be willing to follow study procedures, have a mobile device for telemedicine visits, and score over 4 on the PsAID questionnaire or patient global assessment.Check my eligibility

What is being tested?

The study tests how well patients with psoriatic arthritis respond to structured telemedicine visits aimed at encouraging lifestyle changes. It will evaluate if these remote consultations can improve life quality and disease management effectively.See study design

What are the potential side effects?

Since this trial involves telemedicine rather than medication or invasive procedures, there are no direct side effects associated with typical drug interventions. However, participants may experience discomfort from lifestyle changes.

PsOWell Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My Psoriatic Arthritis symptoms significantly impact my daily life.

Select...

I am between 18 and 89 years old.

Select...

I have Psoriatic Arthritis.

PsOWell Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Effectiveness

Minimal Disease Activity

PsOWell Trial Design

1Treatment groups

Experimental Treatment

Group I: Interventional Telemedicine ArmExperimental Treatment1 Intervention

Single Arm Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Telemedicine

2008

Completed Phase 4

~3540

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,882,122 Total Patients Enrolled

9 Trials studying Psoriatic Arthritis

3,342 Patients Enrolled for Psoriatic Arthritis

Alexis Ogdie-Beatty, MDPrincipal InvestigatorUniversity of Pennsylvania

3 Previous Clinical Trials

440 Total Patients Enrolled

2 Trials studying Psoriatic Arthritis

400 Patients Enrolled for Psoriatic Arthritis

Media Library

Telemedicine Clinical Trial Eligibility Overview. Trial Name: NCT05631223 — N/A

Psoriatic Arthritis Research Study Groups: Interventional Telemedicine Arm

Psoriatic Arthritis Clinical Trial 2023: Telemedicine Highlights & Side Effects. Trial Name: NCT05631223 — N/A

Telemedicine 2023 Treatment Timeline for Medical Study. Trial Name: NCT05631223 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals in their seventies eligible for enrollment in this experiment?

"The current recruitment drive is limited to patients aged between 18 and 89."

Answered by AI

For whom is this trial a viable option?

"This medical experiment is actively looking for 87 individuals with psoriatic arthritis aged between 18 and 89."

Answered by AI

What is the size of the population receiving treatment in this trial?

"Affirmative. Clinicaltrials.gov data suggests that this medical trial is actively seeking participants, with the original post date being March 10th 2023 and the latest update on March 14th 2023. The study requires 87 patients to be enrolled from one location."

Answered by AI

Are there any opportunities for volunteers to join the clinical trial?

"Yes, the online listing on clinicaltrials.gov verifies that this research is currently recruiting participants. This project was initially published on 3/10/2023 and its details were most recently modified on 3/14/2023. A total of 87 people are needed to be enrolled at a lone site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA)

2023. "Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05631223.

All > Psoriatic Arthritis